01—History
Net Income History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $770.9M
1 older move runs past ±150% (largest +2549.5%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is net income?
Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.
What is Royalty Pharma's current net income?
Royalty Pharma (RPRX) annual net income for 2025 was $770.9M, a 10.25% decline from 2024. Royalty Pharma net income for the quarter ending June 30, 2026 was $17.9M.
What was Royalty Pharma's net income in 2024?
Royalty Pharma annual net income for 2024 was $859.0M, a 24.31% decline from 2023.
What was Royalty Pharma's net income in 2023?
Royalty Pharma annual net income for 2023 was $1.13B, a 2549.50% increase from 2022.
What is Royalty Pharma's 5-year net income CAGR?
Royalty Pharma net income grew at a compound annual growth rate (CAGR) of 4.59% from FY2020 to FY2025, going from $975.0M to $770.9M over 5 years.
- Company
- Royalty Pharma
- Ticker
- RPRX
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations